Category Archives: R&D

J.P. Morgan: Suits Take San Francisco

The perennial fat got chewed during the first two days at J.P. Morgan’s annual healthcare conference – buy back stock or raise dividends? – and the usual suspects lurked, but newcomers like Walgreens and not-so-pharma companies like Life Technologies packed the presentation halls and corridors, demonstrating investor and general interest in new ideas, products and [...]
Also posted in Biotech, Deals, Events, Global, Regulatory, Strategy, Technology, healthcare, leadership, pricing | Tagged | Leave a comment

Pharma 2012 Layoffs

brightcove.createExperiences();
Also posted in Emerging Markets, Europe, Global, Manufacturing, Marketing, News, People, Sales, Strategy, Video | Leave a comment

A Glimpse of Health in 2030: Global Trends

The National Intelligence Council’s Global Trends Report explains the scenarios in which the next 18 years may play out internationally. Some of the predictions addressed matters of global health and health technologies playing a role in the future of medicine.
Also posted in Emerging Markets, Global, Strategy, Technology, healthcare | Leave a comment

New York Pharma Forum: Together We Stand

Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
Also posted in Biotech, Events, People, Strategy, Technology, leadership | Tagged , , , , , , , , , , , | Leave a comment

Thinking of Phase IV Trials? Europe Might See Things Differently…

By Peter O’ Donnell. With the shadow cast by Mediator across Europe now receding to a focus on the French law courts, the European Union (EU) said in late November that its pharmacovigilance arrangements offer “one of the most advanced and comprehensive systems in the world”. Certainly the EU’s legislative framework has been significantly boosted over [...]
Also posted in Europe, Global, Guest Blog | Tagged , , , , | Leave a comment